Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC — Stella

Home/Non-Small Cell Lung Cancer/Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

View on ClinicalTrials.gov

Recruiting

Back to Non-Small Cell Lung Cancer trials

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, Tianjin Municipality

Key details

Sponsor

Kong Fanming

Enrollment target

~120 participants

Started

November 2025

Primary completion

December 2027

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.